Literature DB >> 11520172

The transglutaminase, Factor XIIIA, is present in articular chondrocytes.

A K Rosenthal1, I Masuda, C M Gohr, B A Derfus, M Le.   

Abstract

OBJECTIVES: The transglutaminase (TGase) family includes seven different enzymes that catalyse a protein cross-linking reaction resulting in structural and functional alterations in substrate proteins. TGase activity is easily measureable in mature articular cartilage where it may contribute to CPPD deposition disease through its actions on growth factors, crystal components or extracellular matrix proteins. In contrast, low levels of TGase activity are found in chondrocytes from young animals. We previously demonstrated type II TGase protein in articular chondrocytes. Earlier work also suggested the presence of another form of TGase in chondrocytes. We sought to determine if articular chondrocytes contain the TGase, Factor XIIIA (FXIIIA).
METHODS: Western blots with FXIIIA antibody were used to detect FXIIIA in young and old porcine articular chondrocytes and articular cartilage vesicles (ACVs). The presence of FXIIIA mRNA was confirmed by RT-PCR.
RESULTS: Old chondrocyte conditioned medium, cytosol, and membrane fractions contained FXIIIA protein on Western blots, while less FXIIIA was detectable in cell fractions or media from young chondrocytes. ACVs also contained FXIIIA. FXIIIA mRNA was demonstrated by PCR in old and young chondrocytes.
CONCLUSIONS: FXIIIA is present in articular chondrocytes. FXIIIA levels correlate with TGase activity in chondrocytes. The presence of two forms of TGase in articular chondrocytes suggest an important function for this enzyme family in articular cartilage. Copyright 2001 OsteoArthritis Research Society International.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520172     DOI: 10.1053/joca.2000.0423

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  17 in total

1.  Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage.

Authors:  Ann K Rosenthal; Claudia M Gohr; James Ninomiya; Bassam T Wakim
Journal:  Arthritis Rheum       Date:  2011-02

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 3.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

Review 4.  Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy.

Authors:  Hang-Korng Ea; Frédéric Lioté
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

Review 5.  Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician.

Authors:  Salih Pay; Robert Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

6.  Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes.

Authors:  Mark Fahey; Elizabeth Mitton; Emily Muth; Ann K Rosenthal
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

7.  Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation.

Authors:  Kristen A Johnson; David M Rose; Robert A Terkeltaub
Journal:  J Cell Sci       Date:  2008-06-10       Impact factor: 5.285

8.  Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes.

Authors:  Ann K Rosenthal; Claudia M Gohr; Elizabeth Mitton; Vincent Monnier; Todd Burner
Journal:  J Investig Med       Date:  2009-02       Impact factor: 2.895

9.  Articular cartilage vesicles contain RNA.

Authors:  Elizabeth Mitton; Claudia M Gohr; Mark T McNally; Ann K Rosenthal
Journal:  Biochem Biophys Res Commun       Date:  2009-08-11       Impact factor: 3.575

10.  Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis.

Authors:  Miklós Sárdy; Sarolta Kárpáti; Barbara Merkl; Mats Paulsson; Neil Smyth
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.